| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma collected during the first half of gestation.
- Study Design:
- Family/Twin/Trios
- Study Type:
- Parent-Offspring Trios
- Total number of consented subjects: 6
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Study Inclusion/Exclusion Criteria
Trios: Maternal plasma sample, from pregnancy of male fetus, collected during first trimester. Paternal and maternal DNA sample and postnatal child DNA sample.
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Prenatal Care
- Authorized Data Access Requests
-
See articles in PMC citing this study accession
- Study Attribution
-
-
Principal Investigator
- Jay Shendure, PhD. University of Washington, Seattle, WA, USA.
-
Funding Sources
- 1R01HG006283-01. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
-
Principal Investigator